Rezolute Inc (OTCQB:RZLT)

0.498
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
0.39
Today|||52-Week Range
1.25
-43.73%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Internet Software/Services
MARKET CAP
$29.7M

Company Description

Rezolute, Inc. is biopharmaceutical company, which engages in the development of novel and sustained release injectable therapies. Its products includes antriabio 101 for type 1 and type 2 diabetes, and antriabio 301, which an insulin combination for type 2 diabetes only. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Louisville, CO.

Contact Information

Rezolute, Inc.
1450 Infinite Drive
Louisville Colorado 80027
P:(303) 222-2128
Investor Relations:
(650) 549-4175

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Nevan Charles ElamChairman & Chief Executive Officer
Michael DeperroVice President-Operations
Keith A. VendolaChief Financial Officer
Sankaram MantripragadaChief Scientific Officer
Christine FerraraDirector-Clinical Development